HIF‐1 in T cells ameliorated dextran sodium sulfate‐induced murine colitis

Masaaki Higashiyama,R. Hokari,H. Hozumi,C. Kurihara,Toshihide Ueda,C. Watanabe,K. Tomita,Mitsuyasu Nakamura,S. Komoto,Y. Okada,A. Kawaguchi,S. Nagao,M. Suematsu,N. Goda,S. Miura
DOI: https://doi.org/10.1189/jlb.1011518
2012-06-01
Journal of Leukocyte Biology
Abstract:HIF‐1 is active in hypoxia, such as inflamed mucosa, and HIF‐1 in epithelium has been reported to control inflamed mucosa in IBD models. Although T cells play an important role for pathogenesis of IBD, the function of HIF‐1 in T cells remains to be elucidated. We aimed to clarify the function of HIF‐1 in T cells in IBD with focus on the balance between Treg and Teff. Double immunohistochemistry of colonic mucosa in IBD patients showed that HIF‐1 was expressed in T cells infiltrating the inflamed mucosa, suggesting that HIF‐1 in T cells is involved in the pathogenesis. DSS administration to T cell‐specific HIF‐1α KO mice showed more severe colonic inflammation than control mice with the up‐regulation of Th1 and Th17. Hypoxic stimulation in vitro increased Treg activation in WT T cells but not in HIF‐1‐deleted T cells. In contrast, hypoxic stimulation increased Th17 activation, and the degree was higher in HIF‐1‐deleted cells than in control cells. These results show that hypoxia controls intestinal inflammation by regulating cytokine balance in a HIF‐1‐dependent manner, suggesting that strengthening HIF‐1 induction in T cells at the sites of inflammation might be a therapeutic strategy for IBD regulation.
What problem does this paper attempt to address?